IntraClear Founder and Chief Science Officer Ariel Feinerman joins us for a guest editorial in which he asks are non-critical DNA mutations important in...
Mammoth review by Stefano Benvegnù summarises the role of nucleoplasmic transport as a major mechanism for homeostasis and neurotoxicity during healthy and pathological aging.
Throughout...
Cellular energetics has recently been showing promise in the longevity field after deeper research into mitochondrial mechanisms has revealed a potential new biomarker of...
"Different flavours of aging" will change the way people interact and drive personalised medicine.
Continuing our interview with Dr Leanne Jones, Director of the Bakar...
New Bakar Aging Research Institute in San Francisco is an "unparalleled opportunity" for geroscience; its new Director, Dr Leanne Jones, explains why.
Recently we covered...
A recommendation for a commitment to longevity research, focused geroprotective clinical trials and fair access to both is gaining traction in the EU.
The Conference...
The third annual Longevity Leaders World Congress is set to bring together the topics of Aging Science, Aging Well and Financing Longevity.
Framed as "the...
The Senolytic Therapy Network is advancing the fight against aging with outreach and research initiatives – we speak to a co-founder.
The Senolytic Therapy Network...
King's Together Strategic Award Virtual Symposium: 'Metal Fingerprints in Normal Cell States and Disease' – a Virtual Symposium hosted by the London Metallomics Facility,...
EU Green Paper on Ageing is a wish list, but the European Longevity Initiative is proposing a foundation first.
Back in January, the European Commission...
Leading biogerontologist João Pedro de Magalhães says that longevity pharmacology has come of age, and discusses rapamycin, Calico and human trials.
The longevity space is...
Longevity biotech exclusive Q&A with Cambrian Biopharma's CEO – hallmarks of aging and classifying aging as a disease.
Dr James Peyer is Cambrian's CEO and...
Longevity biotech exclusive Q&A with Cambrian Biopharma's Chief Operating Officer.
Recently we reported on Cambrian Biopharma, a New York-based biotech which raised $60 million to...
IntraClear Founder and Chief Science Officer Ariel Feinerman joins us for a guest editorial in which he asks are non-critical DNA mutations important in...
Mammoth review by Stefano Benvegnù summarises the role of nucleoplasmic transport as a major mechanism for homeostasis and neurotoxicity during healthy and pathological aging.
Throughout...
Cellular energetics has recently been showing promise in the longevity field after deeper research into mitochondrial mechanisms has revealed a potential new biomarker of...
Phase 2a study of patients with Alzheimer's or Parkinson's finds that ANVS401 treatment leads to significant improvement in speed and accuracy.
Annovis Bio Inc, a...
Modular multi-material 3D bioprinting solution hopes to develop cost-effective answer to global need for kidney transplants.
Turku-based bioprinting start-up Brinter has today announced the successful closure...
